Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue
Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regu...
Saved in:
Published in | The Journal of immunology (1950) Vol. 168; no. 6; pp. 2979 - 2987 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.03.2002
|
Subjects | |
Online Access | Get full text |
ISSN | 0022-1767 1550-6606 |
DOI | 10.4049/jimmunol.168.6.2979 |
Cover
Loading…
Abstract | Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE2, IL-1β, and TNF-α markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1β and TNF-α requires a proximal promoter region that contains a consensus NF-κB DNA-binding motif. IL-1β- and TNF-α-induced NF-κB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE2 situated at promoter region −171/−163. Moreover, analyses confirm the presence of CREB-1 and NF-κB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-κB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE2-, TNF-α-, and IL-1β-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals. |
---|---|
AbstractList | Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE sub(2), IL-1 beta , and TNF- alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1 beta and TNF- alpha requires a proximal promoter region that contains a consensus NF- Kappa B DNA-binding motif. IL-1 beta - and TNF- alpha -induced NF- Kappa B binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE sub(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF- Kappa B p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF- Kappa B- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE sub(2)-, TNF- alpha -, and IL-1 beta -dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals. Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals. Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals.Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE(2), IL-1beta, and TNF-alpha markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1beta and TNF-alpha requires a proximal promoter region that contains a consensus NF-kappaB DNA-binding motif. IL-1beta- and TNF-alpha-induced NF-kappaB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE(2) situated at promoter region -171/-163. Moreover, analyses confirm the presence of CREB-1 and NF-kappaB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-kappaB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE(2)-, TNF-alpha-, and IL-1beta-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals. Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined the signaling mechanisms through which inflammatory mediators, produced by rheumatoid arthritis (RA) synovial tissue, contribute to the regulation of the NURR subfamily. Markedly enhanced expression of NURR1 is observed in synovial tissue of patients with RA compared with normal subjects. Modulation by proinflammatory mediators in primary RA and normal synoviocytes shows that PGE2, IL-1β, and TNF-α markedly enhance NURR1 mRNA and protein levels in contrast to other subfamily members, NUR77 and NOR-1. We have established that transcriptional activation of the NURR1 gene by IL-1β and TNF-α requires a proximal promoter region that contains a consensus NF-κB DNA-binding motif. IL-1β- and TNF-α-induced NF-κB binding to this site is due predominantly to p65-p50 heterodimer and p50 homodimer subunit protein complexes. We further demonstrate a direct CREB-1-dependent regulation by PGE2 situated at promoter region −171/−163. Moreover, analyses confirm the presence of CREB-1 and NF-κB p50 and p65 subunit binding to the NURR1 promoter under basal conditions in freshly explanted RA synovial tissue. In summary, enhanced NF-κB- and CREB-1-binding activity on the NURR1 promoter by inflammatory mediators delineates novel mechanisms in the regulation of NURR1 transcription. PGE2-, TNF-α-, and IL-1β-dependent stimulation of the NURR1 gene implies that NURR1 induction represents a point of convergence of at least two distinct signaling pathways, suggesting an important common role for this transcription factor in mediating multiple inflammatory signals. |
Author | Murphy, Eithne A. Murphy, Evelyn P. Conneely, Orla M. Ponnio, Tiia McEvoy, Alice N. Bresnihan, Barry FitzGerald, Oliver |
Author_xml | – sequence: 1 givenname: Alice N. surname: McEvoy fullname: McEvoy, Alice N. – sequence: 2 givenname: Eithne A. surname: Murphy fullname: Murphy, Eithne A. – sequence: 3 givenname: Tiia surname: Ponnio fullname: Ponnio, Tiia – sequence: 4 givenname: Orla M. surname: Conneely fullname: Conneely, Orla M. – sequence: 5 givenname: Barry surname: Bresnihan fullname: Bresnihan, Barry – sequence: 6 givenname: Oliver surname: FitzGerald fullname: FitzGerald, Oliver – sequence: 7 givenname: Evelyn P. surname: Murphy fullname: Murphy, Evelyn P. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11884470$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAURi1U1E5LnwAJecUug-0kTrycjlpAKtNqmK4tx75hXCV2sJ1Ks-OZECsegofokzT9Y8GCSvfqbs73Le45RHvOO0DoLSXzghTiw7Xt-9H5bk55PedzJirxCs1oWZKMc8L30IwQxjJa8eoAHcZ4TQjhhBX76IDSui6KiszQr4VO9kYl6x32LV6NugMV8EUYtsrhNWgYkg94dbVeU7wJykUd7PCANzu8Osv-_D7Byhm83OnOarww4Hy0DnB5--Nn9sU7P2x9nNoSTHVx8C4CPu2gB5eyE-uMdd_wZfAJrMPTrLcw9ip5a_AipG2wyUb8def8jVUd3tgYR3iDXreqi3D8dI_Q1dnpZvkpO7_4-Hm5OM90nrOUlQZaVetpTcMbUeU6V5VhgjVasKJtmSaqZNSUTdGYRhDKwDDgZnpuofIc8iP0_rF3CP77CDHJ3kYNXacc-DHKipYk56J-EaQ1EwUrqwl89wSOTQ9GDsH2Kuzks5AJEI-ADj7GAK3UNj3oSUHZTlIi7-XLZ_lyki-5vJc_ZfN_sn_r_5O6Ax5Fu8c |
CitedBy_id | crossref_primary_10_1186_1476_9255_2_15 crossref_primary_10_1186_s12885_016_2291_4 crossref_primary_10_1071_RD14315 crossref_primary_10_1016_j_neuro_2014_04_010 crossref_primary_10_1111_j_1460_9568_2004_03204_x crossref_primary_10_1016_j_brainres_2016_09_031 crossref_primary_10_1074_jbc_M502606200 crossref_primary_10_1111_j_1600_0625_2006_00382_x crossref_primary_10_1002_chem_200701033 crossref_primary_10_1097_00001756_200401190_00020 crossref_primary_10_18632_oncotarget_20747 crossref_primary_10_1016_j_jbspin_2015_09_001 crossref_primary_10_3389_fimmu_2021_676644 crossref_primary_10_1007_s12079_010_0104_0 crossref_primary_10_1093_carcin_bgp161 crossref_primary_10_1074_jbc_M300088200 crossref_primary_10_1016_j_canlet_2020_09_025 crossref_primary_10_1124_mol_104_005801 crossref_primary_10_1165_rcmb_2013_0198OC crossref_primary_10_1002_prp2_973 crossref_primary_10_4049_jimmunol_1701250 crossref_primary_10_1371_journal_pone_0109047 crossref_primary_10_4049_jimmunol_175_1_555 crossref_primary_10_1074_jbc_M507752200 crossref_primary_10_1002_art_20157 crossref_primary_10_1016_j_neulet_2020_135468 crossref_primary_10_1007_s00401_015_1422_3 crossref_primary_10_1038_s12276_021_00555_5 crossref_primary_10_3389_fphar_2022_835697 crossref_primary_10_1186_s12864_016_2469_9 crossref_primary_10_1210_me_2005_0331 crossref_primary_10_1016_j_jsbmb_2011_01_010 crossref_primary_10_1186_s11658_017_0046_0 crossref_primary_10_1016_j_gene_2020_145059 crossref_primary_10_1016_j_lfs_2012_07_003 crossref_primary_10_2353_ajpath_2010_091204 crossref_primary_10_3109_1354750X_2012_706641 crossref_primary_10_3390_ijms20194858 crossref_primary_10_1046_j_1462_5822_2003_00319_x crossref_primary_10_1161_01_ATV_0000098644_03153_6F crossref_primary_10_1136_ard_2009_111690 crossref_primary_10_1002_jcp_28044 crossref_primary_10_1038_sj_jid_5701023 crossref_primary_10_1002_ijc_25600 crossref_primary_10_1016_j_kint_2019_04_009 crossref_primary_10_1002_art_34399 crossref_primary_10_3390_biology10050423 crossref_primary_10_1038_nn_3932 crossref_primary_10_1186_1471_2164_12_610 crossref_primary_10_1074_jbc_M111_272427 crossref_primary_10_1002_art_34554 crossref_primary_10_1074_jbc_M309260200 crossref_primary_10_1002_ajmg_a_35873 crossref_primary_10_1016_j_bbrc_2009_01_086 crossref_primary_10_1007_s00109_019_01866_x crossref_primary_10_1016_j_ajpath_2013_06_029 crossref_primary_10_1097_00002281_200307000_00003 crossref_primary_10_1042_BJ20050196 crossref_primary_10_4049_immunohorizons_1900043 crossref_primary_10_1016_j_jsbmb_2015_04_016 crossref_primary_10_1038_s41598_019_52085_w crossref_primary_10_1016_j_brainresrev_2004_04_007 crossref_primary_10_1016_j_molimm_2018_05_024 crossref_primary_10_3389_fimmu_2019_00085 crossref_primary_10_1016_j_biopha_2024_117802 crossref_primary_10_1111_j_0022_202X_2005_23932_x crossref_primary_10_1002_art_24534 crossref_primary_10_1161_CIRCULATIONAHA_109_885673 crossref_primary_10_1002_stem_122 crossref_primary_10_1016_j_mam_2021_100942 crossref_primary_10_1093_carcin_bgh135 crossref_primary_10_1128_MCB_00385_13 crossref_primary_10_3390_receptors2040018 crossref_primary_10_1016_j_carres_2006_04_041 crossref_primary_10_1002_jmv_29025 crossref_primary_10_1186_s12950_015_0059_2 crossref_primary_10_3389_fnmol_2020_00064 crossref_primary_10_1016_j_molimm_2009_07_019 crossref_primary_10_1111_j_1471_4159_2008_05432_x crossref_primary_10_1016_j_bbrc_2021_03_082 crossref_primary_10_1111_j_0105_2896_2009_00852_x crossref_primary_10_1111_j_1476_5381_2011_01817_x crossref_primary_10_1007_s11095_010_0117_7 crossref_primary_10_2353_ajpath_2007_061000 crossref_primary_10_1007_s10059_010_0015_1 crossref_primary_10_1074_jbc_M116_714873 crossref_primary_10_33549_physiolres_935168 crossref_primary_10_4049_jimmunol_1601301 crossref_primary_10_1210_en_2007_1202 crossref_primary_10_1074_jbc_M608327200 |
Cites_doi | 10.1002/1529-0131(200008)43:8<1673::AID-ANR2>3.0.CO;2-Y 10.1016/0014-5793(95)00956-A 10.1128/mcb.14.5.3469-3483.1994 10.1016/S0021-9258(18)52952-5 10.1007/BF01375656 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D 10.1016/S0378-1119(96)00736-6 10.1172/JCI112350 10.1093/hmg/4.12.2219 10.1093/rheumatology/31.10.653 10.1126/science.3283939 10.1016/S0378-1119(99)00065-7 10.4049/jimmunol.167.1.469 10.1210/mend.6.9.1331771 10.1172/JCI8298 10.1210/mend.11.1.9874 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V 10.1006/bbrc.1994.2900 10.1016/S0092-8674(00)80413-4 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H 10.1083/jcb.102.3.697 10.1056/NEJM200103223441207 10.1210/mend.8.11.7877627 10.1002/art.1780310302 10.3109/08916939808995367 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8 10.1016/S0021-9258(17)44894-0 10.1016/0092-8674(89)90237-7 10.1016/0896-6273(88)90138-9 10.1210/mend.6.12.1491694 10.1002/art.1780400207 10.1172/JCI3756 10.1002/1529-0131(200108)44:8<1761::AID-ART311>3.0.CO;2-D 10.1002/art.1780380202 10.1210/endo.142.2.7926 10.1016/0092-8674(95)90199-X 10.1084/jem.173.3.569 10.1056/NEJM199005033221805 10.1073/pnas.85.22.8444 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I 10.1172/JCI11830 10.1210/endo.141.7.7562 10.1128/MCB.13.10.6124 10.1136/ard.57.8.487 10.1126/science.1925541 10.1136/ard.52.Suppl_1.S39 10.1002/art.1780391103 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.4049/jimmunol.168.6.2979 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 2987 |
ExternalDocumentID | 11884470 10_4049_jimmunol_168_6_2979 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 5WD 79B 85S AARDX AAYXX ABCQX ABDFA ABDPE ABEFU ABEJV ABGNP ABJNI ABOCM ABPPZ ABXVV ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADIPN ADNWM ADXHL AENEX AETEA AFFNX AFHIN AFOSN AFRAH AGORE AHMMS AHWXS AI. AIZAD ALMA_UNASSIGNED_HOLDINGS ARBBW BAWUL BCRHZ BTFSW CITATION D0L DIK DU5 E3Z EBS EJD F5P FRP GX1 IH2 J5H K-O KQ8 L7B MVM NEJ OCZFY OK1 OWPYF P0W P2P PQQKQ R.V RHI ROX RZQ SJN SKT TR2 TWZ VH1 W8F WH7 WOQ X7M XJT XSW XTH YHG ZE2 ZGI ZXP CGR CUY CVF ECM EIF NPM UMC 7T5 H94 KOP 7X8 |
ID | FETCH-LOGICAL-c332t-5defa8cfa8db6b973c3a7d292bc924ff2c0a521d5b4bdb9012ed2e6d0494a33e3 |
ISSN | 0022-1767 |
IngestDate | Fri Sep 05 07:30:51 EDT 2025 Thu Sep 04 20:17:22 EDT 2025 Fri May 23 03:14:12 EDT 2025 Tue Jul 01 01:03:10 EDT 2025 Thu Apr 24 23:12:37 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c332t-5defa8cfa8db6b973c3a7d292bc924ff2c0a521d5b4bdb9012ed2e6d0494a33e3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 11884470 |
PQID | 18294257 |
PQPubID | 23462 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_71503698 proquest_miscellaneous_18294257 pubmed_primary_11884470 crossref_citationtrail_10_4049_jimmunol_168_6_2979 crossref_primary_10_4049_jimmunol_168_6_2979 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2002-03-15 2002-Mar-15 20020315 |
PublicationDateYYYYMMDD | 2002-03-15 |
PublicationDate_xml | – month: 03 year: 2002 text: 2002-03-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2002 |
References | 2022123116294513400_R16 2022123116294513400_R17 2022123116294513400_R18 2022123116294513400_R19 2022123116294513400_R23 2022123116294513400_R24 2022123116294513400_R25 2022123116294513400_R26 2022123116294513400_R20 2022123116294513400_R21 2022123116294513400_R22 2022123116294513400_R49 2022123116294513400_R50 2022123116294513400_R51 2022123116294513400_R12 2022123116294513400_R13 2022123116294513400_R14 2022123116294513400_R15 2022123116294513400_R52 2022123116294513400_R10 2022123116294513400_R11 2022123116294513400_R38 2022123116294513400_R39 2022123116294513400_R2 2022123116294513400_R1 2022123116294513400_R4 2022123116294513400_R3 2022123116294513400_R6 2022123116294513400_R5 2022123116294513400_R8 2022123116294513400_R7 2022123116294513400_R9 2022123116294513400_R40 2022123116294513400_R45 2022123116294513400_R46 2022123116294513400_R47 2022123116294513400_R48 2022123116294513400_R41 2022123116294513400_R42 2022123116294513400_R43 2022123116294513400_R44 2022123116294513400_R27 2022123116294513400_R28 2022123116294513400_R29 2022123116294513400_R34 2022123116294513400_R35 2022123116294513400_R36 2022123116294513400_R37 2022123116294513400_R30 2022123116294513400_R31 2022123116294513400_R32 2022123116294513400_R33 |
References_xml | – ident: 2022123116294513400_R33 doi: 10.1002/1529-0131(200008)43:8<1673::AID-ANR2>3.0.CO;2-Y – ident: 2022123116294513400_R35 doi: 10.1016/0014-5793(95)00956-A – ident: 2022123116294513400_R26 doi: 10.1128/mcb.14.5.3469-3483.1994 – ident: 2022123116294513400_R24 doi: 10.1016/S0021-9258(18)52952-5 – ident: 2022123116294513400_R36 doi: 10.1007/BF01375656 – ident: 2022123116294513400_R42 doi: 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D – ident: 2022123116294513400_R38 doi: 10.1016/S0378-1119(96)00736-6 – ident: 2022123116294513400_R4 doi: 10.1172/JCI112350 – ident: 2022123116294513400_R28 doi: 10.1093/hmg/4.12.2219 – ident: 2022123116294513400_R8 – ident: 2022123116294513400_R6 doi: 10.1093/rheumatology/31.10.653 – ident: 2022123116294513400_R11 doi: 10.1126/science.3283939 – ident: 2022123116294513400_R39 doi: 10.1016/S0378-1119(99)00065-7 – ident: 2022123116294513400_R30 – ident: 2022123116294513400_R45 doi: 10.4049/jimmunol.167.1.469 – ident: 2022123116294513400_R14 doi: 10.1210/mend.6.9.1331771 – ident: 2022123116294513400_R52 doi: 10.1172/JCI8298 – ident: 2022123116294513400_R21 doi: 10.1210/mend.11.1.9874 – ident: 2022123116294513400_R20 – ident: 2022123116294513400_R2 doi: 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V – ident: 2022123116294513400_R19 doi: 10.1006/bbrc.1994.2900 – ident: 2022123116294513400_R50 doi: 10.1016/S0092-8674(00)80413-4 – ident: 2022123116294513400_R31 doi: 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.0.CO;2-H – ident: 2022123116294513400_R37 doi: 10.1083/jcb.102.3.697 – ident: 2022123116294513400_R10 doi: 10.1056/NEJM200103223441207 – ident: 2022123116294513400_R17 doi: 10.1210/mend.8.11.7877627 – ident: 2022123116294513400_R34 doi: 10.1002/art.1780310302 – ident: 2022123116294513400_R51 doi: 10.3109/08916939808995367 – ident: 2022123116294513400_R41 doi: 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.0.CO;2-8 – ident: 2022123116294513400_R5 doi: 10.1016/S0021-9258(17)44894-0 – ident: 2022123116294513400_R13 doi: 10.1016/0092-8674(89)90237-7 – ident: 2022123116294513400_R23 doi: 10.1016/0896-6273(88)90138-9 – ident: 2022123116294513400_R15 doi: 10.1210/mend.6.12.1491694 – ident: 2022123116294513400_R48 – ident: 2022123116294513400_R40 doi: 10.1002/art.1780400207 – ident: 2022123116294513400_R43 doi: 10.1172/JCI3756 – ident: 2022123116294513400_R32 doi: 10.1002/1529-0131(200108)44:8<1761::AID-ART311>3.0.CO;2-D – ident: 2022123116294513400_R44 doi: 10.1002/art.1780380202 – ident: 2022123116294513400_R29 – ident: 2022123116294513400_R27 doi: 10.1210/endo.142.2.7926 – ident: 2022123116294513400_R12 doi: 10.1016/0092-8674(95)90199-X – ident: 2022123116294513400_R3 doi: 10.1084/jem.173.3.569 – ident: 2022123116294513400_R1 doi: 10.1056/NEJM199005033221805 – ident: 2022123116294513400_R16 doi: 10.1073/pnas.85.22.8444 – ident: 2022123116294513400_R9 doi: 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I – ident: 2022123116294513400_R49 doi: 10.1172/JCI11830 – ident: 2022123116294513400_R22 doi: 10.1210/endo.141.7.7562 – ident: 2022123116294513400_R25 doi: 10.1128/MCB.13.10.6124 – ident: 2022123116294513400_R47 doi: 10.1136/ard.57.8.487 – ident: 2022123116294513400_R18 doi: 10.1126/science.1925541 – ident: 2022123116294513400_R7 doi: 10.1136/ard.52.Suppl_1.S39 – ident: 2022123116294513400_R46 doi: 10.1002/art.1780391103 |
SSID | ssj0006024 |
Score | 2.0472486 |
Snippet | Modulation of the NURR subfamily of nuclear receptors may be an important mechanism regulating pathways associated with inflammatory joint disease. We examined... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 2979 |
SubjectTerms | Arthritis, Rheumatoid - genetics Arthritis, Rheumatoid - metabolism Arthritis, Rheumatoid - pathology Cells, Cultured CREB-1 protein Cyclic AMP Response Element-Binding Protein - metabolism Cyclic AMP Response Element-Binding Protein - physiology Dinoprostone - pharmacology DNA - metabolism DNA-Binding Proteins Humans Inflammation Mediators - pharmacology interleukin 1^b Interleukin-1 - pharmacology NF-kappa B - metabolism NF-kappa B - physiology Nuclear Receptor Subfamily 4, Group A, Member 2 NURR1 protein Promoter Regions, Genetic - drug effects Protein Binding - drug effects Protein Binding - genetics Receptors, Cytoplasmic and Nuclear - biosynthesis Receptors, Cytoplasmic and Nuclear - genetics Receptors, Cytoplasmic and Nuclear - metabolism Synovial Membrane - drug effects Synovial Membrane - metabolism Synovial Membrane - pathology Transcription Factors - biosynthesis Transcription Factors - genetics Transcription Factors - metabolism Transcription, Genetic - drug effects Tumor Necrosis Factor-alpha - pharmacology |
Title | Activation of Nuclear Orphan Receptor NURR1 Transcription by NF-κB and Cyclic Adenosine 5′-Monophosphate Response Element-Binding Protein in Rheumatoid Arthritis Synovial Tissue |
URI | https://www.ncbi.nlm.nih.gov/pubmed/11884470 https://www.proquest.com/docview/18294257 https://www.proquest.com/docview/71503698 |
Volume | 168 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIhAvCMotXPeBiofgNFnfso8pSlUhJaCqkfpm7c1KRPFGqVMpfBgfwhcx4_UliRoESIkV-bK2c453Z9YzZwh5PzAy1CIN4UlTgRf4QniyLyOP-xzG-9TXRuN8x3gSnU2Dz5fhZav1ayNqaZXLrvpxa17J_6AK6wBXzJL9B2TrRmEF_AZ8YQkIw_KvMB6qqjiZi8dQWAOiY-GvE5ilghErdtmZTM_P-1gLImu6CDA6J6feN7FYiM6Jy21bK9S7FhrVw9H0DI9Y7MGt2MXMXkOLORZYKQJqTce4oHN0q7VLZ7dYNbNIjpmZFVjBdq5RP2lWaCahLoK9cRkqiPOmRdzkpjn5CsxXcbpQR8Xbt97GXMVYjW7c3OEQrtU0r5Eauozm-QwuvublV5tlc-tYOW-ikjC8x7gi21-WV6KcE65mPxiGf7n8z41shH7sSnrUPXo02KDuVv_MXema3YEjAEcJB47yJrvQQjfq7u4N6C--F1wCt2wQBK7kyY5ed7XpDrnLwHUpyolcNmFHUY8FlYI9XrdTwsLzH99ydtS0LdvbNpz2eEOFVXTxiDwsgaNDx83HpGWyQ3LPFThdH5L74zJ04wn52ZCV2pSWZKWOrLQiKy3ISrfISuWaVmSlJxTISh1ZaU1WGn7YpiqtqEp3qEpLqlL4NFSlNVVpRVXqqPqUTE9HF5_OvLJoiKd8n-VeqE0qBgq-WkaSx77yRawZZ1JxFqQpUz0BJqsOZSC1BGuYGc1MpFEnSfi-8Z-Rg8xm5gWhrCe46fE0BqcDjuRSMS5Z32exEeD4yzZhFSKJKhX1sbDLVQKeNSKaVIgmgGgSJYhom3ysD1o4QZk_7_6ugjqBjh_f5onM2NV10h8wjgPu_j1icPb8iA_a5LnjSHPCklMv9255RR40j9trcpAvV-YNmN-5fFvw-Td62-M4 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+nuclear+orphan+receptor+NURR1+transcription+by+NF-kappa+B+and+cyclic+adenosine+5%27-monophosphate+response+element-binding+protein+in+rheumatoid+arthritis+synovial+tissue&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=McEvoy%2C+Alice+N&rft.au=Murphy%2C+Eithne+A&rft.au=Ponnio%2C+Tiia&rft.au=Conneely%2C+Orla+M&rft.date=2002-03-15&rft.issn=0022-1767&rft.volume=168&rft.issue=6&rft.spage=2979&rft_id=info:doi/10.4049%2Fjimmunol.168.6.2979&rft_id=info%3Apmid%2F11884470&rft.externalDocID=11884470 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |